Clinical aspects of short‐chain acyl‐CoA dehydrogenase deficiency
Open Access
- 29 April 2010
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (5), 507-511
- https://doi.org/10.1007/s10545-010-9080-z
Abstract
Short‐chain acyl‐CoA dehydrogenase deficiency (SCADD) is an autosomal recessive inborn error of mitochondrial fatty acid oxidation. SCADD is biochemically characterized by increased C4‐carnitine in plasma and ethylmalonic acid in urine. The diagnosis of SCADD is confirmed by DNA analysis showing SCAD gene mutations and/or variants. SCAD gene variants are present in homozygous form in approximately 6% of the general population and considered to confer susceptibility to development of clinical disease. Clinically, SCADD generally appears to present early in life and to be most frequently associated with developmental delay, hypotonia, epilepsy, behavioral disorders, and hypoglycemia. However, these symptoms often ameliorate and even disappear spontaneously during follow‐up and were found to be unrelated to the SCAD genotype. In addition, in some cases, symptoms initially attributed to SCADD could later be explained by other causes. Finally, SCADD relatives of SCADD patients as well as almost all SCADD individuals diagnosed by neonatal screening remained asymptomatic during follow‐up. This potential lack of clinical consequences of SCADD has several implications. First, the diagnosis of SCADD should never preclude extension of the diagnostic workup for other potential causes of the observed symptoms. Second, patients and parents should be clearly informed about the potential lack of relevance of the disorder to avoid unfounded anxiety. Furthermore, to date, SCADD is not an optimal candidate for inclusion in newborn screening programs. More studies are needed to fully establish the relevance of SCADD and solve the question as to whether SCADD is involved in a multifactorial disease or represents a nondisease.This publication has 29 references indexed in Scilit:
- Short-chain acyl-coenzyme A dehydrogenase deficiencyMolecular Genetics and Metabolism, 2008
- Mitochondrial fatty acid oxidation defects—remaining challengesJournal of Inherited Metabolic Disease, 2008
- The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular levelHuman Genetics, 2008
- The consequences of extended newborn screening programmes: Do we know who needs treatment?Journal of Inherited Metabolic Disease, 2008
- Multi-minicore DiseaseOrphanet Journal of Rare Diseases, 2007
- Hypoglycaemia and elevated urine ethylmalonic acid in a child homozygous for the short-chain acyl-CoA dehydrogenase 625G > A gene variationActa Paediatrica, 2007
- The 625G>A SCAD gene variant is common but not associated with increased C4‐carnitine in newborn blood spotsJournal of Inherited Metabolic Disease, 2004
- Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiencyThe Journal of Pediatrics, 1995
- Amino acid polymorphism (Gly209Ser) in the ACADS geneHuman Molecular Genetics, 1994
- Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients.JCI Insight, 1987